Flagship Harbor Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-703
| Closed | -$7.42K | – | 640 |
|
|
2023
Q1 | $7.42K | Buy |
+703
| New | +$7.42K | ﹤0.01% | 616 |
|
|
2020
Q4 | – | Sell |
-471
| Closed | -$117K | – | 1284 |
|
|
2020
Q3 | $117K | Hold |
471
| – | – | 0.02% | 610 |
|
|
2020
Q2 | $163K | Hold |
471
| – | – | 0.02% | 509 |
|
|
2020
Q1 | $126K | Buy |
471
+175
| +59% | +$46.8K | 0.03% | 488 |
|
|
2019
Q4 | $96K | Sell |
296
-136
| -31% | -$44.1K | 0.02% | 617 |
|
|
2019
Q3 | $117K | Hold |
432
| – | – | 0.02% | 542 |
|
|
2019
Q2 | $230K | Buy |
432
+58
| +16% | +$30.9K | 0.05% | 365 |
|
|
2019
Q1 | $188K | Buy |
374
+56
| +18% | +$28.2K | 0.04% | 413 |
|
|
2018
Q4 | $156K | Buy |
318
+39
| +14% | +$19.1K | 0.04% | 417 |
|
|
2018
Q3 | $237K | Buy |
279
+85
| +44% | +$72.2K | 0.04% | 367 |
|
|
2018
Q2 | $142K | Buy |
+194
| New | +$142K | 0.03% | 478 |
|